ARJO AB B Logo
SE0010468116
A2H7JW
ARJO-B.ST

ARJO AB B

A carregar cotações...

Previsão

Não temos dados de analistas para esta empresa.


  • Arjo increases organic sales growth, margins hit by US tariffs and currency effects

    Arjo reports Q1 2026 organic sales growth of 3.8%, with adjusted EBITDA of 456 million SEK and an EBITDA margin of 16.9%. Gross margin fell by 110 basis points to 42.6%, weighed notably by US tariffs (‑0.4 percentage points), an unfavorable product and country mix, and currency effects that reduced gross profit by 123 million SEK. Regional divergence: North America +2.2%, Western Europe ‑2.9%, Rest of World +30.0% (large order in South Africa). Management announces a strategic realignment with new financial targets for the second half of 2026 and highlights improved cash conversion (52.7%) and declining net debt as signs of financial strengthening. » Mais em de.investing.com


  • Arjo: share falls after Q4 and full-year figures despite organic growth due to margin pressure

    Arjo reported organic growth of 3.4% in Q4/2025 and annual sales of SEK 11 billion, but showed significant profitability pressure with a declining gross margin (44.7% to 42.1%) and an adjusted EBIT margin of 8.9%. Causes cited include currency effects, US tariffs, an unfavorable product and regional mix, and pricing pressure in the US; net debt and cash flow improved slightly. The share fell about 11% after the results; management confirmed the outlook of 3–5% organic revenue growth for 2026 and plans a strategy review with new financial targets for H2 2026. » Mais em de.investing.com

Em 2026, ARJO AB B já distribuiu € 0,0874 em dividendos. A última distribuição ocorreu em abril.

Dados financeiros da empresa

No último trimestre, ARJO AB B registou receitas de € 248,96 mi e um ganho líquido de € 11,28 mi
(EUR) junho de 2026
YoY
Receitas 248,96 mi 3,59%
Ganho bruto 96,55 mi 7,41%
Ganho líquido 11,28 mi 36,61%
EBITDA 43,13 mi 1,18%

Dados fundamentais

Métrica Valor
Capitalização bolsista
€ 665,41 mi
Número de ações
272,37 mi
Máximo/mínimo de 52 semanas
€ 3,05 - € 2,10
Rentabilidade de dividendos
3,51%
Dividendos TTM
€ 0,0874
Beta
0,69
PER (PE Ratio)
19,41
PEG (PEG Ratio)
-1,92
P/VC (PB Ratio)
0,97
P/V (PS Ratio)
0,69

Perfil da empresa

Arjo AB (publ) entwickelt und vertreibt medizinische Geräte und Lösungen für Patienten mit eingeschränkter Mobilität und altersbedingten Gesundheitsproblemen in Nordamerika, Westeuropa und international. Das Unternehmen bietet Produkte und Lösungen für Patientenhandhabung, Hygiene, Desinfektion, medizinische Betten, Behandlung und Vorbeugung von Druckverletzungen und Beingeschwüren, Vorbeugung von tiefen Venenthrombosen, Behandlung von Ödemen und für Geburtshilfe und Herzdiagnostik. Darüber hinaus bietet das Unternehmen Lösungen für die Bewertung von Demenz- und Bariatriezimmern sowie klinische Beratung, Wartung und Miet- und Finanzierungslösungen für Geräte an. Das Unternehmen beliefert private und öffentliche Einrichtungen, die Akut- und Langzeitpflege anbieten. Das Unternehmen wurde 1957 gegründet und hat seinen Hauptsitz in Malmö, Schweden.

Nome
ARJO AB B
CEO
Andreas Elgaard
Sede Malmö, sn
Suécia
Site
Setor
Cuidados de saúde
Indústria
Cuidados de saúde: equipamentos e produtos
Entrada em bolsa
15/01/2014
Colaboradores 7.000

Símbolos de ticker

Bolsa Símbolo
Sto
ARJO-B.ST
Pnk
ARRJF
Frankfurt
A39.F
Düsseldorf
A39.DU
London
0HQ8.L
Stockholm
ARJO B.ST
München
A39.MU
🍪

Parqet  utiliza cookies. Saber mais